Rituximab Is Associated With Late Onset Neutropenia (Lon) When Administered With Doxorubicin-Based Chemotherapy For The Initial Treatment Of Aggressive B-Cell Lymphomas.

BLOOD(2003)

引用 4|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要